SMAD3 is a key mediator of TGF-β signaling that functions as a tumor suppressor in early gastric carcinogenesis but can promote invasion and metastasis in advanced stages, and its loss is observed in approximately 15%–20% of human gastric cancers. Here, TGFB1 is linked to neoplasm.